Individuals vary their immune response according to age, sex and the costsSeptember 11, 2008Is it always good to respond maximally when pathogens or disease strike, or should individuals vary their immune response to balance immediate and future costs? This is the question evolutionary physiologists Oliver Love, Katrina Salvante, James Dale, and Tony Williams asked when they examined how a simple immune response varied at different life stages across the life-span of individual zebra finches (Taeniopygia guttata), in a study published in the September issue of the American Naturalist. When transitioning from nest-bound juveniles to adults, female immune responses matured slowly whereas males showed dramatic variation potentially due to the costs of molting into their colorful sexually dimorphic plumage. Adult males showed little variation in immune response despite changes in resource quality. Likewise, when females laid eggs under high-quality resource conditions, immune responses were also consistent with those during non-breeding and similar to male responses. However, when laying on reduced resources females reduced their immune response and their reproductive output consistent with a facultative (resource-driven) effect of reproductive effort on immunity. Moreover, even under high-resource conditions during the chick-rearing stage mothers showed reduced immune responses compared to fathers suggesting a residual energetic cost of egg-laying. Perhaps most importantly, immune responses of juveniles of both sexes did not predict their subsequent adult responses. Immune responses of adult females were only predictable when the quality of the environment remained constant; as soon as conditions deteriorated, individual females required flexibility in both the immune and reproductive systems. However, the degree of flexibility came at a cost as only individuals with high immune responses as non-breeders had the capacity to reduce responses when times became tough. These results underlie the fact that immunity is a highly plastic trait that can be modulated in a sex- and context-dependent manner. Given the need for individual flexibility in the immune system, this suggests that an immune response at one stage may provide limited information about immune response at future stages.
University of Chicago Press Journals | |||||||||||||||||||||
|
Related Immune Response Current Events and Immune Response News Articles Researchers identify cell group key to Lyme disease arthritis A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease. Mini heart attacks lessen damage from major ones Researchers have discovered one potential mechanism by which briefly cutting off, then restoring, blood flow to arteries prior to a heart attack lessens the damage caused, according to a study published today in the journal Cardiovascular Research. Study unmasks how ovarian tumors evade immune system Scientists at Johns Hopkins have determined how the characteristic shedding of fatty substances, or lipids, by ovarian tumors allows the cancer to evade the body's immune system, leaving the disease to spread unchecked Researchers discover strategy for predicting the immunity of vaccines In the first study of its kind, researchers at the Yerkes National Primate Research Center and Emory Vaccine Center, Emory University, have developed a multidisciplinary approach involving immunology, genomics and bioinformatics to predict the immunity of a vaccine without exposing individuals to infection. Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models. Results of landmark study of HIV vaccine published in the Lancet Results from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online today in two papers in The Lancet. These analyses of the Step study are being conducted, presented and published to inform the continued search for an effective HIV vaccine. Plastic surgeons warn of malnutrition in body contouring patients Identifying malnutrition before surgery in massive weight loss patients seeking body contouring will significantly decrease surgical complications, accelerate wound healing, improve scar quality and boost patient energy levels, according to a study in the December issue of Plastic and Reconstructive Surgery. Could vitamin D save us from radiation? Radiological health expert Daniel Hayes, Ph.D., of the New York City Department of Health and Mental Hygiene suggests that a form of vitamin D could be one of our body's main protections against damage from low levels of radiation. Engineered killer T cell recognizes HIV-1's lethal molecular disguises Researchers at the University of Pennsylvania School of Medicine and colleagues in the United Kingdom have engineered T cells able to recognize HIV-1 strains that have evaded the immune system. T cell-based HIV vaccine candidate demonstrates positive results The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520. More Immune Response Current Events and Immune Response News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||